Holman RR - Search Results

1

Metformin and risk of cardiovascular disease.

Turner RC, Holman RR. Turner RC, et al. Among authors: holman rr. Cardiology. 1999;91(3):203-4. doi: 10.1159/000006910. Cardiology. 1999. PMID: 10516415 No abstract available.

2

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.

Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA, Holman RR. Kothari V, et al. Among authors: holman rr. Stroke. 2002 Jul;33(7):1776-81. doi: 10.1161/01.str.0000020091.07144.c7. Stroke. 2002. PMID: 12105351

3

Modelling incremental benefits on complications rates when targeting lower HbA_1c levels in people with Type 2 diabetes and cardiovascular disease.

Mostafa SA, Coleman RL, Agbaje OF, Gray AM, Holman RR, Bethel MA. Mostafa SA, et al. Among authors: holman rr. Diabet Med. 2018 Jan;35(1):72-77. doi: 10.1111/dme.13533. Epub 2017 Nov 16. Diabet Med. 2018. PMID: 29057545

4

Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study.

Preiss D, Rankin N, Welsh P, Holman RR, Kangas AJ, Soininen P, Würtz P, Ala-Korpela M, Sattar N. Preiss D, et al. Among authors: holman rr. Diabet Med. 2016 Nov;33(11):1569-1574. doi: 10.1111/dme.13097. Epub 2016 Mar 3. Diabet Med. 2016. PMID: 26887663 Clinical Trial.

5

Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial.

Price HC, Griffin SJ, Holman RR. Price HC, et al. Among authors: holman rr. Diabet Med. 2011 Mar;28(3):363-72. doi: 10.1111/j.1464-5491.2010.03212.x. Diabet Med. 2011. PMID: 21309847 Clinical Trial.

6

Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.

Holman RR, Steemson J, Turner RC. Holman RR, et al. Diabet Med. 1987 Sep-Oct;4(5):457-62. doi: 10.1111/j.1464-5491.1987.tb00909.x. Diabet Med. 1987. PMID: 2959438 Clinical Trial.

7

Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T).

Levy JC, Davies MJ, Holman RR; 4-T Study Group. Levy JC, et al. Among authors: holman rr. Diabetes Res Clin Pract. 2017 Sep;131:161-168. doi: 10.1016/j.diabres.2017.01.022. Epub 2017 Mar 21. Diabetes Res Clin Pract. 2017. PMID: 28750219

8

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for the Study of Diabetes. Nathan DM, et al. Among authors: holman rr. Diabetologia. 2009 Jan;52(1):17-30. doi: 10.1007/s00125-008-1157-y. Epub 2008 Oct 22. Diabetologia. 2009. PMID: 18941734

9

Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.

Hartweg J, Farmer AJ, Perera R, Holman RR, Neil HA. Hartweg J, et al. Among authors: holman rr. Diabetologia. 2007 Aug;50(8):1593-602. doi: 10.1007/s00125-007-0695-z. Epub 2007 May 31. Diabetologia. 2007. PMID: 17541540 Review.

10

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47).

Adler AI, Neil HA, Manley SE, Holman RR, Turner RC. Adler AI, et al. Among authors: holman rr. Am Heart J. 1999 Nov;138(5 Pt 1):S353-9. doi: 10.1016/s0002-8703(99)70035-9. Am Heart J. 1999. PMID: 10539797 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results